Navigation Links
Ingenuity Systems Announces Compliance with HIPAA
Date:2/14/2013

REDWOOD CITY, Calif., Feb. 14, 2013 /PRNewswire/ -- Ingenuity® Systems, a leading provider of biomedical information and analysis solutions, today announced that it has passed the Health Insurance Portability and Accountability Act (HIPAA) audit, confirming that Ingenuity's data center and Ingenuity Variant Analysis are in compliance with relevant Federal Regulations.

HIPAA Certification mandates strong security controls for managing patient information. By meeting the HIPAA compliance guidelines and controls, Ingenuity is able to securely serve clients such as clinical researchers, molecular pathologists and medical geneticists with strict controls on patient security, while providing intuitive web-based applications for quickly analyzing and accurately interpreting the biological meaning and clinical relevance of variant level information from NGS experiments.

"Privacy and data security is of paramount importance to patients and a requirement for us to effectively serve our customers and partners," said David Lewis , Privacy Officer of Ingenuity Systems. "Our HIPAA compliance ensures that all data stored and transferred between Ingenuity and customers is protected and that we are fully prepared to handle patient data in our analysis solutions."

"Data privacy and sharing are important areas when considering data analysis tools. We handle live-patient clinical cases which are extremely sensitive to these issues," stated Bail-Lin Wu, PhD, Genetics Diagnostic Lab Director, Boston Children's Hospital. "We are happy to see Ingenuity continuing to stay at the forefront in security and privacy best practices."

HIPAA certification marks an important milestone in the work with Ingenuity's partners, Laboratory Corporation of America® Holding (LabCorp®) and others, to bring a clinical diagnostic solution to the market for interpreting and classifying large numbers of variants identified by sequencing-based molecular diagnostic tests.

About Ingenuity® Systems
Ingenuity® Systems is a leading provider of biomedical information and analysis solutions for the exploration, interpretation and analysis of complex biological systems in life science research and molecular diagnostics. Today, Ingenuity's solutions are used by tens of thousands of researchers and clinicians at hundreds of leading pharmaceutical, biotechnology, academic, diagnostic and clinical institutions worldwide.


'/>"/>
SOURCE Ingenuity Systems
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Genesis Biosystems Unveils Innovative Skin Treatment at Esthétique SPA International Trade Show
2. BioPharm Systems to Host Webinar on an Add-On Solution for Oracle Clinical
3. Syngenta Licenses Plant Sensory Systems' Technology
4. Europe Anesthesia and Respiratory Devices Market Outlook to 2018 - Respiratory Devices, Respiratory Measurement Devices, Anesthesia Machines, Sleep Apnea Diagnostic Systems, Pain Management Devices and Others
5. Immunology 2013™ Travel Grants Available from R&D Systems
6. First Warning Systems and Unicorp Biotech International Strategic Partner Letter of Intent Signed Breast Cancer Early Detection
7. BioPharm Systems to Host Webinar on Self-service Account Management for Oracle Clinical, Remote Data Capture, and Thesaurus Management System
8. Plant Sensory Systems Awarded $1.8 Million from ARPA-E to Engineer Beets for Biofuel
9. Lucas Bagnell Varga LLC Secures $17.4 Million Award For Former Applied Biosystems Executives
10. R&D Systems Publishes 100,000 Product Detail Web Pages
11. Global Membrane Bioreactor (MBR) Systems Market Worth $2,052 Million by 2017
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... (PRWEB) , ... February 23, 2017 , ... The ... announce a new partnership with Compass Research . GGI's mission is to advance ... vaccine to a child in need in honor of each clinical trial volunteer. The ...
(Date:2/23/2017)... SAN FRANCISCO , Feb. 23, 2017   ... Beyond Type 1, a not-for-profit advocacy and education group ... a grant from Beyond Type 1 to support ViaCyte,s ... and other insulin-requiring diabetes.  For more ... cell-derived cell replacement therapies with a focus on the ...
(Date:2/22/2017)... ... February 22, 2017 , ... ... acquired Kendall Research Systems, LLC (KRS) clinical development program. KRS is ... interface technology for research and clinical applications. The terms of the transaction were ...
(Date:2/22/2017)... , Feb. 22, 2017 Scientists propose in ... and organ damage in Gaucher and maybe other lysosomal ... and lower costs than current therapies. An ... Medical Center , which also included investigators from the ... report their data Feb. 22. The study was conducted ...
Breaking Biology Technology:
(Date:2/21/2017)... 21, 2017 Der weltweite Biobanking-Sektor ... Nach einem Gespräch mit mehr als 50 Vertretern aus verschiedenen ... überwinden gilt, um diese Prognose zu realisieren. ... Zu ... der finanziellen Mittel für die Biobank, die Implementierung Zeit ...
(Date:2/14/2017)... , Feb. 14, 2017  Wake Forest Baptist ... as its new chief executive officer (CEO). Freischlag joins ... John D. McConnell , M.D., who last year ... at the Medical Center, after leading it since 2008. ... full scope of Wake Forest Baptist,s academic health system, ...
(Date:2/13/2017)... Former 9/11 Commission border counsel and Special ... Kephart of Identity Strategy Partners, LLP, today releases ... "Executive Order: Protecting the Nation From Foreign Terrorist Entry ... "As President Trump,s ,Travel Ban, Executive Order gains more ... the travel ban, it is important that our national ...
Breaking Biology News(10 mins):